Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to -$319.2 million.

  • Takeda Pharmaceutical's Treasury Shares fell 9536.73% to -$319.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$319.2 million, marking a year-over-year decrease of 9536.73%. This contributed to the annual value of -$491.1 million for FY2025, which is 23818.21% down from last year.
  • As of Q1 2023, Takeda Pharmaceutical's Treasury Shares stood at $209917.6, which was down 2350.67% from $274426.1 recorded in Q1 2022.
  • In the past 5 years, Takeda Pharmaceutical's Treasury Shares registered a high of $274426.1 during Q1 2022, and its lowest value of $92886.0 during Q1 2019.
  • Moreover, its 5-year median value for Treasury Shares was $170904.3 (2020), whereas its average is $174247.0.
  • In the last 5 years, Takeda Pharmaceutical's Treasury Shares skyrocketed by 7742.49% in 2022 and then tumbled by 24177.59% in 2025.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Treasury Shares stood at -$800.7 million in 2021, then increased by 11.32% to -$710.1 million in 2022, then surged by 51.17% to -$346.7 million in 2023, then skyrocketed by 52.89% to -$163.4 million in 2024, then plummeted by 95.37% to -$319.2 million in 2025.
  • Its Treasury Shares stands at -$319.2 million for Q4 2025, versus -$333.4 million for Q3 2025 and -$857.8 million for Q2 2025.